Oxford Immunotec Inc., a medical diagnostics company founded in 2002, wants to put its first U.S. location outside of its Massachusetts headquarters in Memphis.

The company’s European headquarters is in Abingdon, England, and Massachusetts is home to the company’s North American headquarters.

The company, which is developing new testing for diseases based on its patented T-cell measurement technology, would focus its proposed Memphis location at 5846 Distribution Drive on testing blood specimens for analysis using the company’s T-SPOT TB test. That test is the company’s first product and a new cellular blood test for the detection of active and latent TB infection.

The company is looking for a $100,000 Economic and Community Development grant from the state to offset the costs of developing the site. Oxford also expects to invest more than $1.8 million and hire 25 employees by the end of 2014 for the Memphis facility.

The company’s request will be discussed at the Economic Development Growth Engine (EDGE) board meeting Wednesday, Feb. 15.